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Background: Matrix metalloproteinase-9 (MMP-9) plays a crucial role in pathological processes of brain
inflammation, injury, and neurodegeneration. Moreover, bradykinin (BK) induces the expression of several
inflammatory proteins in brain astrocytes. Recent studies have suggested that increased oxidative stress is
implicated in the brain inflammation and injury. However, whether BK induced MMP-9 expression mediated
through oxidative stress remains virtually unknown. Herein we investigated the role of redox signals in BK-induced
MMP-9 expression in rat brain astrocytes (RBA-1 cells).
Results: In the study, we first demonstrated that reactive oxygen species (ROS) plays a crucial role in BK-induced
MMP-9 expression in cultured brain astrocytes (in vitro) and animal brain tissue (in vivo) models. Next, BK-induced
MMP-9 expression is mediated through a Ca2+-mediated PKC-α linking to p47phox/NADPH oxidase 2 (Nox2)/ROS
signaling pathway. Nox2-dependent ROS generation led to activation and up-regulation of the downstream
transcriptional factor AP-1 (i.e. c-Fos and c-Jun), which bound to MMP-9 promoter region, and thereby turned on
transcription of MMP-9 gene. Functionally, BK-induced MMP-9 expression enhanced astrocytic migration.
Conclusions: These results demonstrated that in RBA-1 cells, activation of AP-1 (c-Fos/c-Jun) by the
PKC-α-mediated Nox2/ROS signals is essential for up-regulation of MMP-9 and cell migration enhanced by BK.
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Reactive oxygen speciesBackground
Matrix metalloproteinases (MMPs) is a large family of
zinc-dependent endopeptidases, which play an important
role in the turnover of extracellular matrix (ECM) and
pathophysiological processes [1]. In the central nervous
system (CNS), MMPs, in particular MMP-9, have been
shown to be involved in morphogenesis, wounding heal-
ing, and neurite outgrowth, [2]. Up-regulation of MMP-
9 has been induced by various brain injuries, which may* Correspondence: chuenmao@mail.cgu.edu.tw
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reproduction in any medium, provided the orparticipate in the pathogenesis of brain diseases [3].
Moreover, cytokines and lipopolysaccharide (LPS) have
been shown to induce MMP-9 expression and activity in
culture rat brain astrocytes [4,5]. These studies demon-
strated that MMP-9 may be involved in brain inflamma-
tion and injury.
Reactive oxygen species (ROS) are produced by various
enzymatic and chemical processes or directly inhaled, in-
cluding O2
- , ·OH, and hydrogen peroxide (H2O2). The
ROS at low level have physiological roles as signaling
molecules in various cellular and developmental pro-
cesses [6,7] and killing of invading microorganisms [8].
In contrast, recent report indicated that oxidative stress
plays an important role in the progression of various. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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with DNA, lipids, proteins, and carbohydrates that lead
to cellular dysfunctions and inflammatory responses
[7,9]. Under pathological conditions, many proinflamma-
tory mediators like bradykinin (BK) induce expression of
several inflammatory genes during brain injury by in-
creasing ROS production [7,10]. Recently, increasing evi-
dence attributes the neurodegenerative diseases such as
Alzheimer’s disease (AD) to oxidative stress (generation
of free radicals) that leads to brain inflammation during
CNS pathogenesis [7,10,11]. Moreover, ROS also exert as
a signaling factor mediated microglial activation induced
by several proinflammatory mediators [12]. Although the
effects of BK associated with ROS generation have been
reported in several organ diseases [13], BK-induced
ROS-mediated MMP-9 responses are not well character-
ized in rat brain astrocytes (RBA-1) cells.
BK and related peptides are elevated during brain
trauma, stroke, and neuroinflammation [14]. Among
brain cells, astrocytes possess a B2-type BK receptor
which is a G protein-coupled receptor (GPCR) coupling
to a Gq protein to activate PLCβ, phosphoinositide
breakdown, Ca2+ mobilization, PKC, and ROS gener-
ation [15,16]. These signaling pathways regulate several
cellular responses including proliferation, migration, and
gene expression. Moreover, the 5’ region of MMP-9 pro-
moters has been characterized to possess a series of
functional enhancer element-binding sites such as NF-
κB, Ets, and AP-1 [17]. BK has been shown to regulate
expression of several genes through different transcrip-
tion factors including AP-1 [18] and NF-κB [19]. In
astrocytes, MMP-9 expression induced by various stim-
uli was mediated through activation of either NF-κB or
AP-1 [20-22]. However, the molecular mechanisms of
ROS associated with MMP-9 expression and cellular
function (motility) induced by BK in RBA-1 cells are not
completely defined.
Accordingly, BK may play an important role in regula-
tion of ROS signal and specific gene expression, such as
MMP-9 and enhancing inflammatory responses. The
experiments were performed to investigate the molecu-
lar mechanisms of ROS signaling pathways involved in
BK-induced MMP-9 expression in RBA-1 cells and an
animal model. In the study, we found that BK induces
MMP-9 expression via a ROS-dependent pathway. A
Ca2+/PKC-α-dependent Nox2/ROS generation cascade
contributes to AP-1 induction and activation, which is
required for MMP-9 expression and cell motility in
RBA-1 cells.
Results
BK induces MMP-9 expression via ROS-dependent manner
ROS have been shown to induce MMPs expression in
various cell types [23]. To determine whether ROSparticipates in MMP-9 induction, a ROS scavenger
(NAC) was used. Pretreatment with a NAC (10 mM)
attenuated BK-induced MMP-9 protein and mRNA ex-
pression (Figure 1A, B). To explore BK-stimulated ROS
generation and the efficacy of NAC, a ROS indicator
(DCF-DA) was used. As shown in Figure 1C, BK-
stimulated ROS generation was attenuated by pretreat-
ment with NAC, demonstrating that NAC can efficiently
scavenge ROS in these cells. To further investigate
whether BK induces MMP-9 transcription activity via
ROS-dependent manner, a rat MMP-9 promoter
reporter-luciferase construct was used. The data showed
that BK stimulated an increase of MMP-9 promoter ac-
tivity which was attenuated by pretreatment with NAC
(Figure 1D). These results suggested that ROS contrib-
ute to BK-induced MMP-9 expression via enhancing its
gene transcriptional activity in RBA-1 cells.
We further confirmed whether BK-induced ROS-
dependent MMP-9 expression also occurred in rat brain
cortex tissue (in vivo). As shown in Figure 1E, the
images of immunofluorescence staining showed that in-
jection with BK induced MMP-9 expression as com-
pared with that of control (sham), which was attenuated
by pretreatment with NAC in rat brain cortex tissue.
Consistently, pretreatment with NAC markedly attenu-
ated BK-induced MMP-9 protein and mRNA expression
(in vivo) determined by Western blot, gelatin zymogra-
phy, and real-time PCR, demonstrating that BK induces
MMP-9 gene expression via a ROS-dependent manner
in in vivo studies. To further confirm BK-induced ROS-
dependent MMP-9 expression in brain astrocytes, the
rat brain primary astrocytes were isolated and cultured.
As expected, pretreatment with NAC concentration-
dependently inhibited BK-induced MMP-9 expression
determined by gelatin zymography (Figure 1F). These
results indicated that BK-induced ROS-dependent
responses in RBA-1 cells, are similar to those of either
animal model or rat primary cultured astrocytes. Thus,
the following experiments were performed using RBA-1
cells throughout this study.
Nox2-derived ROS generation contributes to BK-induced
MMP-9 expression
The NADPH oxidase (Nox) is considered to be a major
source of ROS in several physiological and pathological
processes [8,24]. To explore whether Nox is involved in
BK-induced MMP-9 expression, as shown in Figure 2A,
B, BK-induced MMP-9 protein and mRNA expression
was attenuated by pretreatment with a Nox inhibitor
diphenyleneiodonium (DPI, 1 μM). To further investi-
gate whether BK stimulates Nox activity, as shown in
Figure 2C, BK time-dependently stimulated Nox activity
which was attenuated by pretreatment with DPI (1 μM)
in RBA-1 cells. To determine which Nox isoforms
Figure 1 ROS is a fundamental element during BK-induced MMP-9 expression in RBA-1 cells. (A) Cells were pretreated without or with
N-acetylcysteine (NAC, 10 mM) for 1 h before exposure to 10 nM BK for 24 h. The conditioned media were collected for zymographic analysis of
MMP-9 expression and activity. (B) Cells were pretreated with or without NAC for 1 h before exposure to BK for 16 h. The total RNA was collected
and analyzed by RT-PCR. (C) Cells were incubated with the DCF-DA (5 μM) for 45 min, followed by stimulation with 10 nM BK for 5 min in
presence or absence of NAC. The fluorescence intensity of cells was determined. (D) Cells were transiently cotransfected with 0.9 μg of
pGL-MMP9-Luc and 0.1 μg of pGal coding for β-galactosidase for overnight. Cells were treated with BK for 16 h in the absence or presence of
NAC (10 mM) for 1 h before being harvested for measuring the luciferase and β-galactosidase activities. (E) Immunofluorescence staining for
MMP-9 or GFAP in serial sections of the brain cortex tissue from vehicle-treated rat (Sham), BK-injected rat (BK), or NAC-pretreated rat (NAC/BK).
The arrow indicates GFAP-positive cells overlapping with MMP-9 expression. DAPI was used to stain the nucleus. Image of fluorescence
microscope, 400×. Similarly, the MMP-9 protein and mRNA of brain cortex tissues (Sham, BK, and NAC/BK) were analyzed by Western blot,
zymography, and real-time PCR. (F) Rat primary astrocytes were isolated and cultured, and pretreated with or without NAC (1 or 10 mM) before
exposure to BK for 24 h. The conditioned media and cell lysates were collected and analyzed by zymography and Western blotting. Data are
expressed as the mean ± SEM (n = 3). *P < 0.05; #P < 0.01, as compared with the respective values of cells stimulated with BK only.
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Figure 2 NADPH oxidase-dependent ROS generation is involved in BK-induced MMP-9 expression in RBA-1 cells. (A) Cells were
pretreated without or with DPI (1 μM) for 1 h before exposure to 10 nM BK for the indicated time intervals. The conditioned media were
collected for zymographic analysis of MMP-9 expression. (B) Cells were pretreated with or without DPI (1 μM) for 1 h before exposure to 10 nM
BK for 16 h. The total RNA was collected and analyzed by RT-PCR. (C) Cells were pretreated without or with DPI (1 μM) for 1 h and then
incubated with 10 nM BK for the indicated time intervals or 5 min. The Nox activity was analyzed. (D) The total RNA was collected and analyzed
Nox isotypes expression by RT-PCR. (E) Cells were transfected with scramble (scra) or Nox2 siRNA for 24 h, followed by incubation with 10 nM BK
for 24 h. The conditioned media and cell lysates were collected for zymography of MMP-9 or Western blotting to determine the levels of Nox2
and GAPDH (as an internal control). Data are expressed as the mean ± SEM (n = 3). *P < 0.05; #P < 0.01, as compared with the respective values of
cells stimulated with vehicle (C) and BK (A-C, E) only. The figure represents one of three similar experiments.
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forms was analyzed by RT-PCR. The data showed that
Nox1, Nox2, and Nox4 were expressed in RBA-1 cells
and Nox2 predominantly expressed in comparison with
those of Nox1 and Nox4 mRNA levels (Figure 2D).
Next, the involvement of Nox2 in BK-induced responses
was confirmed by transfection with Nox2 siRNA. As
shown in Figure 2E, transfection of cells with Nox2
siRNA knocked down Nox2 protein expression and atte-
nuated BK-induced MMP-9 expression in RBA-1 cells.
These results suggested that BK-induced MMP-9 expres-
sion is mediated through Nox(2)-dependent ROS gener-
ation in RBA-1 cells.
Involvement of p47phox/Nox2-dependent ROS generation
in BK-induced MMP-9 expression
Nox is a multimeric protein complex consisting of at
least three cytosolic subunits of p47phox, p67phox, and
p40phox. p47phox has been shown to organize the trans-
location of other cytosolic factors, hence its designationas “organizer” [25]. Here, to investigate the role of
p47phox in BK-induced MMP-9 expression, a p47phox
subunit inhibitor apocynin (Apo) was used. The results
showed that pretreatment with Apo (10 μM) attenuated
BK-induced MMP-9 protein and mRNA expression
(Figure 3A, B). We next determined whether the trans-
location of p47phox involved in BK-induced responses, as
shown in Figure 3C, BK stimulated translocation of
p47phox from the cytosol to the membrane with a max-
imal response within 3 min, which was attenuated by
pretreatment with Apo. These results were further sup-
ported by the data of immunofluorescence images using
a fluorescent microscope (Figure 3C). To ascertain that
p47phox is essential for BK-stimulated Nox-dependent
ROS generation, the Nox activity and ROS generation
were detected. As shown in Figure 3D, pretreatment
with Apo (10 μM) inhibited the BK-stimulated Nox acti-
vation and ROS generation (Figure 3D). To further en-
sure the effect of p47phox on BK-induced MMP-9
expression, as shown in Figure 3E, transfection with
Figure 3 BK induces MMP-9 expression via p47phox translocation in RBA-1 cells. (A) Cells were pretreated without or with Apocynin (Apo,
10 μM) for 1 h before exposure to 10 nM BK for the indicated time intervals. The conditioned media were collected for zymographic analysis of
MMP-9 expression. (B) Cells were pretreated with or without Apo (10 μM) for 1 h before exposure to 10 nM BK for 16 h. The total RNA was
collected and analyzed by RT-PCR. (C) Cells were pretreated without or with Apo (10 μM) for 1 h treated with 10 nM BK for the indicated time
intervals or 3 min. The membrane and cytosol fractions were prepared and analyzed by Western blotting. The p47phox translocation was also
confirmed by immunofluorescent staining. (D) Cells were pretreated without or with Apo (10 μM) for 1 h before exposure to 10 nM BK for 5 min.
The Nox activity and ROS generation were analyzed. (E) Cells were transfected with scramble (scra) or p47phox siRNA for 24 h, followed by
incubation with 10 nM BK for 24 h. The conditioned media and cell lysates were collected for zymography of MMP-9 or Western blotting to
determine the levels of Nox2 and GAPDH (as an internal control). Data are expressed as the mean ± SEM (n = 3). *P < 0.05; #P < 0.01, as compared
with the respective values of cells stimulated with vehicle (C) and BK (A, B, D, E) only. The figure represents one of three similar experiments.
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protein expression and blocked BK-induced MMP-9
expression. These results suggested that p47phox/Nox-
dependent ROS generation plays a crucial role in
BK-induced MMP-9 expression in RBA-1 cells.
Role of Ca2+ in BK-induced ROS generation and MMP-9
expression
Induction of MMP-9 by several stimuli is mediated
through Ca2+-dependent pathways [21,26]. Therefore, to
investigate whether intracellular Ca2+ change involves in
BK-induced responses, an intracellular Ca2+ chelator
(BAPTA/AM) and an ER Ca2+-ATPase blocker (thapsi-
gargin, TG) were used. Pretreatment with either
BAPTA/AM (30 μM) or TG (1 μM) markedly attenuated
BK-induced MMP-9 protein and mRNA expression
(Figure 4A, B). Next, to determine the role of intracellu-
lar Ca2+ increase in BK-induced responses, an intracellu-
lar Ca2+ indicator Fura-2/AM was used. As shown in
Figure 4C, BK stimulated a rapid increase in intracellular
Ca2+ under normal buffer (solid line). To differentiateCa2+ release from intracellular stores or Ca2+ influx
from the extracellular fluid, the same experiments
were performed under Ca2+-free buffer. The data
showed that BK also stimulated an intracellular Ca2+
increase under Ca2+-free condition, but smaller than
those of normal buffer, which was attenuated by pre-
treatment with 1 μM TG (Figure 4C, lower panel),
suggesting that BK stimulates intracellular Ca2+ in-
crease via TG-sensitive intracellular Ca2+ stores and
extracellular Ca2+ influx. We also determined the
interplay between Ca2+ and Nox/ROS generation in
BK-induced MMP-9 expression. The data showed that
pretreatment with either Apo (10 μM) or DPI (1 μM)
had no effect on BK-stimulated intracellular Ca2+ in-
crease (Figure 4C, lower panel). In contrast, pretreat-
ment with either BAPTA/AM (30 μM) or TG (1 μM)
significantly attenuated BK-stimulated Nox activity and
ROS generation (Figure 4D). These results indicated
that intracellular Ca2+ increase is essential for BK-
induced Nox/ROS-dependent MMP-9 expression in
RBA-1 cells.
Figure 4 BK-induced Ca2+ release from internal TG-sensitive Ca2+ store plays a role in BK-induced MMP-9 expression. (A) Cells were
pretreated without or with BAPTA/AM (30 μM) or TG (1 μM) for 1 h before exposure to 10 nM BK for the indicated time intervals. The
conditioned media were collected for zymographic analysis of MMP-9 expression. (B) Cells were pretreated with or without BAPTA/AM (30 μM) or
TG (1 μM) for 1 h before exposure to 10 nM BK for 16 h. The total RNA was collected and analyzed by RT-PCR. (C) For Ca2+ mobilization,
confluent cultures of RBA-1 cells on glass coverslips were loaded with Fura-2/AM and fluorescent measurement of [Ca2+]i was carried out in a
dual excitation wavelength spectrofluorometer, with excitation at 340 nm and 380 nm. Cells were incubated in Ca2+-containing normal buffer
(solid line) or Ca2+-free buffer (dot line) and then exposed to BK at 50 sec. In a Ca2+-free buffer, cells were pretreated with or without TG (1 μM),
Apo (10 μM), or DPI (1 μM) for 30 min, exposed to BK at 50 sec, and then 2 mM Ca2+ was added to the cells. (D) RBA-1 cells were pretreated
without or with BAPTA/AM (30 μM) or TG (1 μM) for 1 h and then incubated with 10 nM BK for 5 min. The Nox activity and ROS generation were
analyzed. Data are expressed as the mean ± SEM (n = 3). *P < 0.05; #P < 0.01, as compared with the respective values of cells stimulated with BK
only. The figure represents one of three similar experiments.
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PKC-α manner
PKC isoforms such as PKC-α have been shown to regu-
late MMP-9 expression in various cell types [27]. Our
recent report also suggested that BK-stimulated Nox/
ROS signaling might be mediated through PKC [16].
Thus, to investigate which PKC isoforms are involved in
BK-induced resposnes, pretreatment with either a pan-
PKC inhibitor GF109203X (30 μM) or a selective PKC-α
inhibitor Gö6976 (1 μM) attenuated BK-induced MMP-
9 expression (Figure 5A, B), suggesting that PKC(α) is
involved in BK-induced MMP-9 expression in RBA-1
cells. Moreover, the activation of PKC-α in BK-inducedresponses was further confirmed by determining its
translocation from the cytosol to the membrane. As
shown in Figure 5C, BK stimulated PKC-α translocation
in a time-dependent manner with a maximal response
within 5 min (Figure 5C, upper part), which was attenu-
ated by pretreatment with either BAPTA/AM (30 μM)
or Gö6976 (1 μM) (Figure 5C, lower part). We further
examined the role of PKC-α in BK-stimulated Nox-
derived ROS generation, pretreatment with GF109203X
or Gö6976 attenuated the BK-stimulated Nox activation
and ROS generation (Figure 5D), suggesting that PKC(α)
is involved in these responses. To further ensure the role
of PKC-α in MMP-9 expression, as shown in Figure 5E,
Figure 5 Involvement of PKC-α in BK-induced ROS generation and MMP-9 expression in RBA-1. (A) Cells were pretreated without or with
GF109203X (GF, 30 μM) or Gö6976 (Gö, 1 μM) for 1 h before exposure to 10 nM BK for the indicated time intervals. The conditioned media were
collected for zymographic analysis of MMP-9 expression. (B) Cells were pretreated with or without GF109203X (GF, 30 μM) or Gö6976 (Gö, 1 μM)
for 1 h before exposure to 10 nM BK for 16 h. The total RNA was collected and analyzed by RT-PCR. (C) Cells were pretreated with or without
BAPTA (BAP, 30 μM) or Gö (1 μM) for 1 h and then treated with 10 nM BK for the indicated time intervals (upper part) or 5 min (lower part). The
membrane and cytosol fractions were prepared and analyzed by Western blotting. (D) Cells were pretreated without or with GF or Gö for 1 h
before exposure to 10 nM BK for 5 min. The Nox activity and ROS generation were analyzed. (E) Cells were transfected with scramble (scra) or
PKC-α siRNA for 24 h, followed by incubation with 10 nM BK for 24 h. The conditioned media and cell lysates were collected and analyzed by
zymography or Western blotting. (F) Cells were pretreated without or with Gö (1 μM), BAPTA (30 μM), or TG (1 μM) for 1 h before exposure to 10
nM BK for 5 min. The cell lysates were collected and analyzed by Western blotting using an anti-phospho-serine (p-Ser), p47phox, or GAPDH
antibody. Data are expressed as the mean ± SEM (n = 3). *P < 0.05; #P < 0.01, as compared with the respective values of cells stimulated with
vehicle (C) and BK (A, B, D-F) only. The figure represents one of three similar experiments.
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http://www.biosignaling.com/content/10/1/35ttransfection with PKC-α siRNA knocked down PKC-α
protein expression and attenuated BK-induced MMP-9
expression. To determine whether PKC-α is an upstream
molecule of p47phox activation, as shown in Figure 5F,
pretreatment with Gö6976 (1 μM) significantly attenu-
ated BK-stimulated phosphorylation of p47phox at serine
residues. Moreover, pretreatment with either BAPTA/
AM (30 μM) or TG (1 μM) also attenuated phosphoryl-
ation of p47phox (Figure 5F). These results demonstrated
that PKC-α contributes to BK-induced Nox (p47phox)/
ROS generation and MMP-9 expression in RBA-1 cells.
Activation of AP-1 is required for BK-induced MMP-9
expression
AP-1-dependent pathway has been shown to involve in
MMP-9 expression in various cell types [22]. To deter-
mine whether AP-1 is required for MMP-9 induction byBK, an AP-1 inhibitor (tanshinone IIA) was used. As
shown in Figure 6A, BK-induced MMP-9 expression was
attenuated by pretreatment with tanshinone IIA (TSIIA,
10 μM). The expression and nuclear accumulation of
AP-1 serve as an indicator of downstream gene activa-
tion [28]. Thus, we examined whether BK stimulates nu-
clear accumulation of AP-1 (i.e. c-Fos and c-Jun) in
RBA-1 cells. First, we found that BK stimulated an accu-
mulation of c-Fos and c-Jun (phospho-c-Jun) in nucleus
within 30 min, which was blocked by BAPTA/AM
(30 μM), Gö6976 (1 μM), apocynin (10 μM), DPI (1 μM),
or NAC (10 mM) (Figure 6B). To determine whether BK
enhanced AP-1 transcriptional activity, a promoter con-
taining AP-1 binding sites reporter construct was used.
The data showed that BK stimulated an increase in AP-1
promoter activity which was significantly inhibited by
pretreatment with BAPTA/AM (30 μM), TG (1 μM),
Figure 6 AP-1 (c-Fos/c-Jun) is essential for BK-induced MMP-9 expression through a Ca2+/PKC-α/Nox2/ROS cascade. (A) Cells were
pretreated without or with tanshinone IIA (TSIIA, 10 μM) for 1 h before exposure to 10 nM BK for the indicated time intervals. The conditioned
media were collected for zymographic analysis of MMP-9 expression. (B) Cells were pretreated without or with BAPTA (BAP, 30 μM), Gö6976 (Gö,
1 μM), Apo (10 μM), DPI (1 μM), or NAC (10 mM) for 1 h before exposure to 10 nM BK for 30 min. The nuclear fraction was collected and
analyzed by Western blotting using an anti-c-Fos, phospho-c-Jun, or c-Jun antibody. (C) Cells were transiently cotransfected with pAP1-Luc and
pGal for 24 h, pretreated with BAPTA (BAP), TG, Gö, Apo, DPI, or NAC for 1 h and then incubated with BK for 6 h. The AP-1 promoter activity in
the cell lysates was determined. (D) Cells were transfected with scramble (scra) or c-Fos/c-Jun siRNA for 24 h, followed by incubation with 10 nM
BK for 24 h. The conditioned media and cell lysates were collected and analyzed by zymography or Western blotting. Data are expressed as the
mean ± SEM (n = 3). *P < 0.05; #P < 0.01, as compared with the respective values of cells stimulated with BK only. The figure represents one of
three similar experiments.
Lin et al. Cell Communication and Signaling 2012, 10:35 Page 8 of 15
http://www.biosignaling.com/content/10/1/35Gö6976 (1 μM), Apo (10 μM), DPI (1 μM), or NAC
(10 mM) (Figure 6C). To further confirm the role of AP-
1 in BK-induced MMP-9 expression, cells were trans-
fected with c-Fos or c-Jun siRNA. The results showed
that transfection with c-Fos or c-Jun siRNA significantly
knocked down respective c-Fos or c-Jun proteins and
attenuated BK-induced MMP-9 expression (Figure 6D).
These results suggested that BK stimulates AP-1 (i.e.
c-Fos and c-Jun) activation via the PKC-α-dependent
Nox2/ROS generation, which is essential for up-regulation
of MMP-9 in RBA-1 cells.
BK enhances recruitment of AP-1 to MMP-9 promoter and
astrocytic migration
MMP-9 promoter region contains AP-1 binding sites
[29]. Hence, we used ChIP-PCR assay to determine
whether BK stimulates recruitment of AP-1 to MMP-9
promoter leading to MMP-9 expression. We designed a
pair of primers for MMP-9 promoter (-597 to -318) re-
gion, containing an AP-1 binding site. Chromatin was
immunoprecipitated using an anti-c-Fos or anti-c-Jun
antibody, and the MMP-9 promoter region (-597 to
-318) was amplified by PCR. As shown in Figure 7A
(upper part), BK time-dependently stimulated binding ofc-Fos and c-Jun to the MMP-9 promoter with a maximal
response within 30 min, which was attenuated by pre-
treatment with BAPTA/AM, Gö6976, Apo, DPI, or NAC
(Figure 7A, lower part). We next examined whether BK-
induced MMP-9 promoter activity is also regulated by
these signaling components. We have constructed a
MMP-9 promoter into a pGL3-basic vector containing
the luciferase reporter system (pGL-MMP-9-Luc), which
contains the AP-1 binding sites [30]. BK stimulated an
increase in MMP-9 promoter activity which was attenu-
ated by pretreatment with BAPTA/AM, Gö6976, Apo,
or DPI and transfection with c-Fos or c-Jun siRNA
(Figure 7B), suggesting that BK-induced MMP-9 pro-
moter activity is mediated through PKC-α, Nox/ROS,
and AP-1 in RBA-1 cells. To further determine the func-
tional role of AP-1 transcription factor in BK-induced
MMP-9 promoter induction, wild-type (WT) and point-
mutated (mt)-AP1 MMP-9 promoter constructs (as
illustrated in Figure 7C, upper part) were tested for in-
duction by BK. As shown in Figure 7C, BK driven
MMP-9 promoter activity was totally lost in AP1 pro-
moter mutant, thus indicating that AP-1 binding domain
is required for MMP-9 promoter activation by BK in
RBA-1 cells. These results confirmed that BK-increased
Figure 7 BK induces astrocytic migration through Nox/ROS-dependent AP-1 increasing MMP-9 gene expression. (A) Cells were
incubated with BK (10 nM) for the indicated times (upper part), or pretreated with BAPTA (BAP, 30 μM), Gö6976 (Gö, 1 μM), Apo (10 μM), DPI
(1 μM), or NAC (10 mM) for 1 h and then incubated with 10 nM BK for 30 min. The c-Fos and c-Jun AP-1 binding activity were analyzed by
chromatin-IP (ChIP)-PCR assay. (B) Cells were transiently cotransfected with pGL-MMP9-Luc and pGal for 24 h, pretreated with BAPTA (BAP), Gö,
Apo, DPI, or transfection with c-Fos or c-Jun siRNA for 24 h and then incubated with BK for 16 h. (C) Schematic representation of the different
MMP-9-luciferase constructs, either wild-type (WT) or modified by single-point mutation of the AP-1 binding site (upper part). After cotransfection,
luciferase activities of different MMP-9-promoter constructs after stimulation with or without BK (10 nM) for 16 h, were measured as relative MMP-
9 promoter activity to that of β-galactosidase. (D) Cells were plated on 6-well culture plates, grew to confluence and starved with serum-free
DMEM/F-12 medium for 24 h. Cells were pretreated with TG, Gö, Apo, DPI, NAC, TSIIA, or MMP-9i (9i) for 1 h and the monolayer cells were
manually scratched with a blue tip as described in Methods, and then incubated with BK (10 nM) for 48 h. Phase contrast images of cells were
taken at 48 h and the number of cell migration was counted as described in Methods. (E) Rat primary cultured astrocytes were pretreated with
BAPTA (BAP), Gö, Apo, DPI, NAC, or TSIIA before exposure to BK for 16 h. The conditioned media and total RNA were collected and analyzed by
zymography and RT-PCR. Data are expressed as the mean ± SEM (n = 3). #P < 0.01, as compared with the respective values of cells stimulated
with BK only.
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of AP-1 (c-Fos/c-Jun) to the MMP-9 promoter region.
Ultimately, to demonstrate the functional effect of up-
regulated MMP-9 by BK, we evaluated the cell migration
of RBA-1 cells. The images of cell migration induced by
BK (10 nM) were observed and taken at 48 h
(Figure 7D, inset panel). The number of migratory cells
was counted and the statistical data were presented in
Figure 7D. The data showed that pretreatment with TG(1 μM), Gö6976 (1 μM), Apo (10 μM), DPI (1 μM),
NAC (10 mM), TSIIA (10 μM), or MMP-9i (9i, 1 μM)
significantly blocked BK-induced cell migration, suggest-
ing that BK-induced MMP-9 expression and cell migra-
tion is mediated through Ca2+/PKC-α-dependent Nox2/
ROS and AP-1 cascade in RBA-1 cells.
To confirm these results in primary culture astrocytes,
the rat primary cultured astrocytes were pretreated with
BAPTA (BAP), Gö, Apo, DPI, NAC, or TSIIA before
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media and total RNA were collected and analyzed by
zymography and RT-PCR analysis. As shown in
Figure 7E, pretreatment with BAPTA (BAP), Gö, Apo,
DPI, NAC, or TSIIA significantly inhibited BK-induced
MMP-9 protein and mRNA expression, suggesting that
BK induced MMP-9 expression via Ca2+-dependent
PKC-α, Nox-derived ROS, and AP-1 pathways in the pri-
mary cultured astrocytes.
Discussion
MMP-9 expression and activation play a critical role in
tissue remodeling associated with the pathogenesis of
brain diseases [3]. Reduction of MMP activity by
pharmacological inhibitors or gene knock-out strategies
protects the brain from BBB disruption, cell death, and
advanced neuroinflammation [2,29]. Moreover, BK and
related peptides are simultaneously produced and
released following brain injury [14]. The role of BK
implicated in astrocytic functions is not completely
understood. Thus, we investigated the molecular
mechanisms underlying BK-induced MMP-9 expression
in cultured RBA-1 cells and an animal model. Our
results suggest that in brain astrocytes, activation of Ca2
+/PKC-α-dependent Nox2/ROS signal leading to induc-
tion of AP-1 (c-Fos/c-Jun) is essential for BK-induced
MMP-9 gene expression and enhancing cell migration.
The findings suggest that BK-induced MMP-9 expres-
sion and cell migration may contribute to increase BBB
permeability and recruit immune cells, leading to brain
inflammation and edema. In addition, astrocytic migra-
tion may be involved in brain inflammation and remod-
eling during brain injuries such as brain wound healing,
tissue remodeling, and glial scar formation [2,3,19,20].
Imbalance in the level of ROS has been shown to play
a causative role in numerous pathologies of degenerative
diseases [23,31]. ROS concentration-dependently exert a
key role in the normal physiological functions and the
inflammatory responses [9]. In the brain, ROS also ex-
tend to the control of vascular tone which is tightly
modulated by metabolic activity within neurons [6].
Moreover, increasing ROS generation by diverse stimuli
can regulate the expression of inflammatory mediators
in pathogenesis of brain disorders [24,31]. Recently, the
cellular damage in neurodegenerative disorders such as
Alzheimer’s disease is attributed to oxidative stress
[7,10,11]. BK-induced ROS generation has been reported
in cerebral arterioles and renal diseases [13]. In this
study, our data demonstrated that in both in vitro and
in vivo studies, BK induces MMP-9 expression via ROS-
dependent pathways in brain astrocytes. Moreover, we
found that BK-induced MMP-9 expression is mediated
through Nox-dependent ROS generation, since pretreat-
ment with ROS scavenger NAC or Nox activity inhibitorDPI attenuated BK-induced responses. The involvement
of Nox-dependent ROS generation in BK-induced
responses was further confirmed by NAC or DPI in
RBA-1 cells. ROS exert as a major signaling factor which
mediates microglial activation induced by inflammatory
mediators, including LPS [12]. Herein we are the first
group to establish that Nox-dependent intracellular
redox signal (ROS generation) contributes to MMP-9
expression induced by BK in brain astrocytes.
Moreover, Nox is considered to be a major source of
ROS in several physiological and pathological processes
[8,24]. To date, there are five isoforms of Nox have been
discovered, including Nox1-5 [24]. Nox1, Nox2, and
Nox4 have been shown to be expressed and are crucial
for ROS generation in brain cells [8,32]. First, our
data demonstrated that Nox activity is involved
in BK-induced responses by a Nox inhibitor DPI
(Figure 2A-C). As previous reports, we also found that
RBA-1 cells express Nox1, Nox2, and Nox4 (Figure 2D).
Next, BK-induced MMP-9 expression is predominantly
mediated through activation of Nox2, confirmed by re-
spective Nox siRNAs (Figure 2E). The involvement of
Nox in BK-induced responses is mediated through phos-
phorylation and translocation of p47phox (a Nox2 com-
ponent) which was attenuated by a p47phox inhibitor
apocynin or p47phox siRNA (Figure 3). These results are
consistent with previous studies showing that Nox is
expressed in astrocytes and contributes to ROS gener-
ation [16,33] and Nox is involved in LPS-induced MMPs
expression in Raw264.7 [34]. Additionally, we also
demonstrated that BK-stimulated Nox2-dependent ROS
signal and MMP-9 expression is mediated through Ca2
+-dependent PKC-α activation, confirmed by an intracel-
lular Ca2+ chelator (BAPTA/AM), the inhibitor of ER
Ca2+-ATPase (TG), pan-PKC (GF109203X), or PKC-α
(Gö6976) and PKC-α siRNA (Figure 4, 5). These data
demonstrated that BK stimulates Ca2+-dependent PKC-α
activation linking to Nox2/ROS generation and MMP-9
expression in RBA-1 cells. It is consistent with previous
studies indicating that overexpression of PKC-α can in-
crease phosphorylation of p47phox and induce both its
translocation and Nox activation in human neutrophils
[35].
The excessive increase of oxidative stress during injur-
ies not only causes oxidative damage to cellular macro-
molecules, but also modulates the pattern of gene
expression through functional alterations of transcrip-
tion factors. The transcription factor AP-1 is well known
to be modulated during oxidative stress associated with
inflammatory diseases [36]. Moreover, BK-induced gene
expression has been shown to be mediated through one
of transcription factors such as AP-1 [18]. However, the
mechanistic connection between the MMP-9 expression
and the ROS-dependent pathway induced by BK has not
Figure 8 Scheme of the BK-mediated signals linked to MMP-9
expression and brain astrocytic migration. Binding of BK to its
specific receptors (B2R) stimulates activation of Ca2+/PKC-α/Nox2/
ROS cascade. MMP-9 transcription is AP-1-dependently regulated by
an ROS-dependent pathway. This signaling pathway may contribute
to sustained expression of MMP-9 which is required for cell
migration in brain astrocytes (RBA-1 cells).
Lin et al. Cell Communication and Signaling 2012, 10:35 Page 11 of 15
http://www.biosignaling.com/content/10/1/35been established in RBA-1 cells. In this study, we
demonstrated that AP-1 is essential for BK-induced
MMP-9 expression which was inhibited by an AP-1 in-
hibitor TSIIA (Figure 6A). The involvement of AP-1 in
BK-induced responses was further confirmed by deter-
mining induction of AP-1 (c-Fos/c-Jun), including phos-
phorylation of c-Jun, accumulation of c-Fos in nucleus,
and AP-1 promoter reporter activity. These responses
were attenuated by the Ca2+ chelator (BAPTA/AM), the
inhibitor of PKC-α (Gö6976), p47phox (apocynin), Nox
(DPI), or a ROS scavenger (NAC), suggesting that the
Ca2+/PKC-α/p47phox/Nox/ROS cascade is involved in ac-
tivation of AP-1 which contributes to BK-induced
MMP-9 expression in RBA-1 cells. Moreover, the role of
AP-1 in BK-induced MMP-9 expression was also con-
firmed by either c-Fos or c-Jun siRNA to inhibit BK-
induced MMP-9 expression. These results are consistent
with the involvement of AP-1 in MMP-9 expression
induced by ox-LDL and LTA in RBA-1 cells [21,22].
To confirm AP-1 indeed binds to the promoter region
of MMP-9 gene, the binding activity of AP-1 was deter-
mined by a ChIP-PCR assay. In this study, BK stimulated
AP-1 (c-Fos and c-Jun) recruitment and activation via
Ca2+/PKC-α-dependent Nox/ROS cascade and enhan-
cing MMP-9 promoter activity. We further confirmed
that AP-1 binding site (-503 to -497) within MMP-9
promoter is required for BK-induced MMP-9 transcrip-
tional activity by using an AP-1-mutated MMP-9 pro-
moter construct. These results demonstrated that
activation of AP-1 (either c-Fos or c-Jun) is essential for
BK-induced MMP-9 gene expression which is mediated
through a Ca2+/PKC-α-dependent Nox/ROS signal in
RBA-1 cells. It is consistent with previous studies show-
ing that AP-1 is involved in MMP-9 expression in vari-
ous cell types [22,37].
Several reports have shown the multiple effects of BK
and MMP-9 on brain glial cells [30,38]. In brain injury,
up-regulation of BK, ROS, and MMP-9 may increase
BBB permeability, recruit immune cells infiltrating
through BBB into the tissues, and subsequently result in
brain inflammation and edema [38]. In this study, we
suggested that BK-induced Nox2-mediated ROS signal,
MMP-9 expression, and astrocytic migration might be
involved in brain inflammation and remodeling during
brain injuries. Both ROS [39] and MMP-9 [37] have
been reported to play a critical role in cell motility in
several cell types. Herein we demonstrated that BK
induces MMP-9 expression and cell migration via PKC-
α-dependent Nox/ROS signaling pathway in RBA-1 cells.
The results are consistent with recent reports indicating
that the ROS-dependent MMP-9 expression is essential
for cell migration by various stimuli such as TGF-β1 or
LPS [20,34]. Hence, we suggest that ROS-mediated
MMP-9 up-regulation by BK is associated with cellmigration in RBA-1 cells. Taken together, BK, ROS, and
MMP-9 may have multiple effects on different types of
brain glial cells, inducing inflammatory and remodeling
roles.
Conclusions
We have demonstrated that BK directly induces MMP-9
expression via Ca2+-dependent PKC-α, p47phox/Nox2-
mediated ROS generation, linking to activation of AP-1
(c-Fos/c-Jun), which results in the cell migration in
RBA-1 cells. Based on the observations from literatures
and our findings, Figure 8 depicts a model for the
molecular mechanisms underlying BK-induced MMP-9
expression and functional changes (e.g. migration) in
RBA-1 cells. These findings concerning BK-induced
Nox-dependent redox signal and MMP-9 up-regulation
in brain astrocytes imply that BK-mediated ROS signals
might play a critical role in the modulation of brain
injuries and inflammatory diseases.
Methods
Materials
Dulbecco’s modified Eagle’s medium (DMEM)/Ham’s
nutrient mixture F-12 (F-12), fetal bovine serum (FBS),
and PKC-α, p47phox, Nox2, c-Fos and c-Jun siRNAs were
purchased from Invitrogen (Carlsbad, CA). Hybond C
membrane and enhanced chemiluminescence (ECL)
detection system were from GE Healthcare Biosci-
ences (Buckinghamshire, UK). MMP-9 antibody was
from NeoMarker (Fremont, CA). PKC-α, p47phox, Nox1,
Nox2, Nox4, phospho-c-Jun, c-Fos, and c-Jun antibodies
were from Santa Cruz (Santa Cruz, CA). All primary
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BAPTA/AM, thapsigargin, GF109203X, Gö6976, apocy-
nin, diphenyleneiodonium chloride (DPI), and tanshi-
none IIA (TSIIA) were from Biomol (Plymouth Meeting,
PA). Bicinchoninic acid (BCA) protein assay reagent was
from Pierce (Rockford, IL). BK, N-acetyl cysteine (NAC),
enzymes, and other chemicals were from Sigma (St.
Louis, MO).
Cell cultures and treatment
The RBA-1 originated from a primary cultured astro-
cyte of neonatal rat cerebrum and was naturally devel-
oped through successive cell passages [30] and used
throughout this study. Primary astrocyte cultures were
prepared from the cortex of 6-day-old Sprague-Dawley
rat pups [30]. The purity of primary cultured astro-
cytes was assessed using an astrocyte-specific marker,
glial fibrillary acidic protein (GFAP), showing over
95% GFAP-positive astrocytes. Cells were plated onto
12-well culture plates and made quiescent at conflu-
ence by incubation in serum-free DMEM/F-12 for
24 h, and then incubated with BK at 37°C for the
indicated time intervals. When the inhibitors were
used, cells were pretreated with the inhibitor for 1 h
before exposure to BK.
Animal model and experimental procedures
All animals were treated in accordance with Chang
Gung University guidelines, and the animal protocols
were approved by Chang Gung University’s Adminis-
trative Panel on Laboratory Animal Care. Male
Sprague-Dawley rats (250-300 g) were anesthetized
with Pentothal (30 mg/kg, i.p.) and placed in a stereo-
tactic frame. A 30-gauge needle attached to a 1.0-ml
Hamilton microsyringe was inserted into the cortex via
a polyethylene tube (4.0 mm lateral to the midline,
2.0 mm anterior to the coronal suture of the bregma,
2.5 mm below the surface of the skull, and then with-
drawn 0.5 mm), and 30 μl of BK (1 μM) was injected
over 1 minute using a microsyringe pump. As a control
experiment, 30 μl of sterile 0.1% BSA was infused in
the same way. After infusion, the needle was slowly
removed. The burr hole was sealed with bone wax and
the incision was closed. Rectal temperature was con-
trolled within the normal range (37±5°C) during sur-
gery with a homeothermic blanket. The animals were
maintained at 25°C with ad libitum access to food
and water. To evaluate the involvement of ROS in
BK-induced MMP-9 expression, the rats were pre-
treated with a ROS scavenger NAC (150 mg/kg, i.v.)
for 1 h before the BK injection for 24 h. To examine
the MMP-9 expression and astrocytes’ localization in
brain cortex, immunofluorescence staining was per-
formed on the first and second serial sections of thebrain, which were deparaffinized, rehydrated, and
washed with PBS. Non-specific binding was blocked
by preincubation with PBS containing 5% BSA for
1 h at room temperature. The sections were incu-
bated with an anti-MMP-9 or anti-GFAP antibody for
the positive localization and identification of astro-
cytes for overnight at 4°C. The sections were washed
and then incubated with a fluorescein isothiocyanate
(FITC)-conjugated goat anti-mouse or anti-rabbit sec-
ondary antibody and observed by using a fluorescence
microscope (ZEISS, Axiovert 200 M), 400×.MMP gelatin zymography
Growth-arrested cells were incubated with BK for the
indicated time intervals. Treatment of RBA-1 cells with
pharmacological inhibitors or BK alone had no signifi-
cant effect on cell viability determined by an XTT assay
(data not shown). The cultured media were analyzed by
gelatin zymography [19]. Gelatinolytic activity was mani-
fested as horizontal white bands on a blue background.
Because cleaved MMPs were not reliably detectable, only
pro-form zymogens were quantified.Total RNA extraction and reverse transcription-PCR
analysis
Total RNA was extracted from RBA-1 cells [19]. The
cDNA obtained from 0.5 μg total RNA was used as a
template for PCR amplification. Oligonucleotide primers
were designed on the basis of Genbank entries for rat
MMP-9, Nox1-4 [17] and β-actin. The following primers
were used for amplification reaction: MMP-9, 5’-AGTT
TGGTGTCGCGGAGCAC-3’ (sense), 5’-TACATGAGC
GCTTCCGGCAC-3’ (antisense); Nox1, 5’-TACGAAGT
GGCTGTACTGGTTG-3’ (sense), 5’-CTCCCAAAGGA
GGTTTTCTGTT-3’ (antisense); Nox2, 5’-TCAAGTGT
CCCCAGGTATCC-3’ (sense), 5’-CTTCACTGGCTGT
ACCAAAGG-3’ (antisense); Nox3, 5’-AATCACAGAG
TCTGCCTGGACT-3’ (sense), 5’-ATCCAGACTTTCA
TCCCAGTGT-3’ (antisense); Nox4, 5’-GGAAGTCCAT
TTGAGGAGTCAC-3’ (sense), 5’-TGGATGTTCACAA
AGTCAGGTC-3’ (antisense); β-actin, 5’-GAACCCTAA
GGCCAACCGTG-3’ (sense), 5’-TGGCATAGAGGTCT
TTACGG-3’ (antisense).
The amplification was performed in 30 cycles at 55°C,
30 s; 72°C, 1 min; 94°C, 30 s. PCR fragments were ana-
lyzed on 2% agarose in 1X TAE gel containing ethidium
bromide and their sizes were compared to molecular
weight markers. Amplification of β-actin, a relatively in-
variant internal reference RNA, was performed in paral-
lel, and cDNA amounts were standardized to equivalent
β-actin mRNA levels. These primer sets specifically
recognize only the genes of interest as indicated by amp-
lification of a single band of the expected size (754 bp
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for Nox3, 244 bp for Nox4, and 514 bp for β-actin).
Preparation of cell extracts and Western blotting analysis
Growth-arrested cells were incubated with BK for the
indicated time intervals. The cell lysates were collected
and the protein concentration was determined by the
BCA reagents according to the instructions of the manu-
facturer. Samples from these cell lysates (30 μg protein)
were denatured and subjected to SDS-PAGE using a
10% (w/v) running gel. The phosphorylation of p47phox
or c-Jun was analyzed by Western blot [19]. The immu-
noreactive bands were detected by ECL reagents.
Measurement of intracellular ROS generation
The peroxide-sensitive fluorescent probe 2’,7’-dichloro-
fluorescein diacetate (DCF-DA) was used to assess the
generation of intracellular ROS [40] with minor modifi-
cations. RBA-1 cells on monolayers were incubated with
5 μM DCF-DA in RPMI-1640 for 45 min at 37°C. The
supernatant was removed and replaced with fresh
RPMI-1640 medium before exposure to BK (10 nM).
Relative fluorescence intensity was recorded over time
(3-120 min) by using a fluorescent plate reader (Thermo,
Appliskan) at an excitation wavelength of 485 nm and
emission was measured at a wavelength of 530 nm, and
fluorescent images were also obtained by using a fluores-
cence microscopy (ZEISS, Axiovert 200 M).
Determination of NADPH oxidase activity by
chemiluminescence assay
The NADPH oxidase activity in intact cells was assayed
by lucigenin chemiluminescence [41]. After incubation,
the cells were gently scraped and centrifuged at 400 × g
for 10 min at 4°C. The cell pellet was resuspended in a
known volume (35 μl/well) of ice-cold RPMI 1640
medium, and the cell suspension was kept on ice. To a
final 200 μl of pre-warmed (37°C) RPMI 1640 medium
containing either NADPH (1 μM) or lucigenin (20 μM),
5 μl of cell suspension (2 × 104 cells) was added to initi-
ate the reaction followed by immediate measurement of
chemiluminescence using an Appliskan luminometer
(ThermoW) in an out-of-coincidence mode. Appropriate
blanks and controls were established, and chemilumines-
cence was recorded. Neither NADPH nor NADH
enhanced the background chemiluminescence of luci-
genin alone (30-40 counts/min). Chemiluminescence
was continuously measured for 12 min, and the activity
of NADPH oxidase was expressed as counts per million
cells.
Transient transfection with siRNAs
Transient transfection of small interfering RNA
(siRNA) duplexes corresponding to rat PKC-α, p47phox,Nox2, c-Fos, c-Jun, and scrambled siRNAs (100 nM)
was performed using a LipofetamineTM RNAiMAX re-
agent (Invitrogen) according to the manufacturer’s
instructions.
Plasmid construction, transfection, and luciferase reporter
gene assays
The upstream region (-1280 to +19) of the rat MMP-9
promoter was cloned to the pGL3-basic vector contain-
ing the luciferase reporter system [30]. Additionally, the
introduction of a mismatched primer mutation into the
AP-1 to generate pGL3-MMP-9ΔAP-1 was performed,
using the following (forward) primer: ΔAP-1: 5’-GCAG
GAGAGGAAGCTGAGTTGAAGACA-3’. All plasmids
were prepared by using QIAGEN plasmid DNA prepar-
ation kits. These constructs were transfected into RBA-1
cells by using a Lipofectamine reagent according to the
instructions of manufacture. The transfection efficiency
(~60%) was determined by transfection with enhanced
GFP. After incubation with BK, cells were collected and
disrupted by sonication in lysis buffer (25 mM Tris, pH
7.8, 2 mM EDTA, 1% Triton X-100, and 10% glycerol).
After centrifugation, aliquots of the supernatants were
tested for promoter activity using a luciferase assay sys-
tem (Promega, Madison, WI). Firefly luciferase activities
were standardized for β-galactosidase activity.
Isolation of cell fractions
Cells were harvested, sonicated for 5 s at output 1.5 with
a sonicator (Misonix, Inc., Farmingdale, NY), and centri-
fuged at 8,000 rpm for 15 min at 4°C. The pellet was
collected as the nuclear fraction. The supernatant was
centrifuged at 14,000 rpm for 60 min at 4°C to yield the
pellet (membrane fraction) and the supernatant (cyto-
solic fraction).
Measurement of intracellular Ca2+ level
Intracellular Ca2+ signaling was measured in confluent
monolayers with a calcium-sensitive dye Fura-2/AM as
described by Grynkiewicz et al. [42]. Upon confluence,
the cells were cultured in serum-free DMEM/F-12 for
24 h before measurements were made. The Ca2+ level
was determined using Fura-2/AM as an indicator in a
temperature-controlled holder of a Hitachi F-4500 spec-
trofluorometer (Tokyo, Japan), as previously described
[19]. The autofluorescence of each monolayer was sub-
tracted from the fluorescent data. The ratios (R) of the
fluorescence at the two wavelengths are computed and
used to calculate changes in intracellular Ca2+ level.
Immunofluorescence staining
Growth-arrested cells were treated with 10 nM BK for
the indicated time intervals, washed twice with ice-cold
PBS, fixed with 4% (w/v) paraformaldehyde in PBS for
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in PBS for 15 min. The staining was performed by incu-
bating with 10% normal goat serum in PBS for 30 min
followed by incubating with an anti-p47phox antibody
(1:200 dilution) for 1 h in PBS with 1% BSA, washing
thrice with PBS, incubating for 1 h with a FITC-
conjugated goat anti-rabbit antibody (1:200 dilution) in
PBS with 1% BSA, washing thrice with PBS, and finally
mounting with aqueous mounting medium. The
images observed under a fluorescence microscope
(ZEISS, Axiovert 200 M).
Chromatin immunoprecipitation assay
To detect the in vivo association of nuclear proteins with
rat MMP-9 promoter, chromatin immunoprecipitation
(ChIP) analysis was conducted as previously described
[30]. Briefly, RBA-1 cells were cross-linked with 1% for-
maldehyde for 10 min at 37°C and washed thrice with
ice-cold PBS containing 1 mM phenylmethylsulfonyl
fluoride (PMSF) and 1% aprotinin. Soluble chromatin
was prepared using a ChIP assay kit (Upstate) according
to the manufacturer’s recommendations and immuno-
precipitated without (control) or with anti-c-Fos or anti-
c-Jun antibody and normal goat immunoglobulin G
(IgG). Following washes and elution, precipitates were
heated overnight at 65°C to reverse cross-linking of
DNA and protein. DNA fragments were purified by
phenol-chloroform extraction and ethanol precipitation.
The purified DNA was subjected to PCR amplification
using the primers specific for the region (-597 to -318)
containing the distal AP-1 binding site (-503 to -497)
present in the MMP-9 promoter region, sense primer:
5’-AGAGCCTGCTCCCAGAGGGC-3’; antisense pri-
mer: 5’-GCCAAGTCAGGCAGGACCCC-3’. PCR frag-
ments were analyzed on 2% agarose in 1X TAE gel
containing ethidium bromide and the size (279 bp) was
compared to a molecular weight marker.
Cell migration assay
RBA-1 cells were cultured to confluence in 6-well cul-
ture plates and starved with serum-free DMEM/F-12
medium for 24 h. The monolayer cells were manually
scratched with a pipette blue tip to create extended and
definite scratches in the center of the dishes with a
bright and clear field (~2 mm). The detached cells were
removed by washing the cells once with PBS. Serum-free
DMEM/F-12 medium with or without BK (10 nM) was
added to each dish as indicated after pretreatment with
the inhibitors for 1 h, containing a DNA synthesis in-
hibitor hydroxyurea (10 μM) during the period of ex-
periment. Images of migratory cells from the scratched
boundary were observed under a light microscope with
a digital camera (Olympus, Japan). Numbers of migra-
tory cells were counted from the resulting four phaseimages for each point and then averaged for each experi-
mental condition. The data presented are summarized
from three separate assays.
Statistical analysis of data
All the data were estimated using a GraphPad Prism
Program (GraphPad, San Diego, CA). Data were
expressed as the mean±SEM and analyzed by one-way
analysis of variance followed with Tukey’s posthoc test.
P < 0.05 was considered significant.
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